文献速递关节外科

高危初次全关节置换术中万古霉素粉末与稀释聚维酮碘冲洗的1年感染率:多中心随机对照试验

The One-Year Infection Rates After Vancomycin Powder and Dilute Povidone-Iodine Lavage in High-Risk Primary Total Joint Arthroplasty: A Multicenter Randomized Controlled Trial.
PubMed 文献 · J Arthroplasty · 2026-04-24

该多中心随机对照试验纳入2053例高危初次单侧全髋或全膝关节置换患者,随机分为万古霉素粉末、稀释聚维酮碘、联合方案或生理盐水冲洗四组,主要结局为1年因假体周围感染导致翻修手术。1年时全髋组和全膝组各方案间PJI率均无显著差异(P=0.62和P=0.05)。

要点

  • 高危初次全髋/膝置换中,万古霉素粉末、聚维酮碘冲洗或联合方案与生理盐水冲洗相比,1年PJI率无显著差异。
  • 全髋队列PJI率0.5%-1.9%(P=0.62),全膝队列0%-2.0%(P=0.05),均未达统计学显著。
  • 术中抗菌预防方案对长期感染结局的影响可能有限。

核心结论

  • 在高危初次全髋或全膝关节置换患者中,万古霉素粉末、稀释聚维酮碘冲洗、联合方案与生理盐水冲洗相比,1年假体周围感染率无显著差异。
  • 术中抗菌和抗生素方案可能对长期感染结局影响有限。

研究设计与样本

  • 前瞻性多中心随机对照试验,纳入2053例高危初次单侧全髋或全膝关节置换患者,随机分为四组:万古霉素粉末、稀释聚维酮碘、万古霉素联合聚维酮碘方案、生理盐水冲洗对照。
  • 主要结局为1年因假体周围感染导致翻修手术,采用符合方案集分析,按手术类型分层卡方检验。
  • 1年时完整随访全髋798例、全膝1032例(排除退出、失访和9例无关死亡)。

主要发现

  • 全髋队列:万古霉素组PJI 0.5%,聚维酮碘组1.7%,联合组1.9%,生理盐水组1.1%(P=0.62)。
  • 全膝队列:万古霉素组PJI 1.6%,聚维酮碘组0%,联合组2.0%,生理盐水组0.4%(P=0.05)。
  • 0-3个月、3-12个月及0-12个月合并分析各组间均无显著差异(全髋P=0.14、0.67、0.62;全膝P=0.13、0.80、0.05)。

临床怎么用

  • 对于高危初次全髋或全膝关节置换患者,术中万古霉素粉末或稀释聚维酮碘冲洗并未显著降低1年PJI风险。
  • 临床决策应综合考虑其他感染预防措施,而非单纯依赖术中局部抗菌方案。

局限性

  • 1年随访存在退出、失访和无关死亡,最终分析样本量少于随机化样本。
  • 全膝队列PJI率组间比较P=0.05,接近显著性阈值但未达到统计学显著。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Given the severe morbidity, mortality, and substantial cost of periprosthetic joint infection (PJI), substantial research has been conducted to compare perioperative and postoperative infection-prevention strategies. To our knowledge, there are no studies to date that have evaluated the 1-year efficacy of intraoperative vancomycin powder and/or dilute povidone-iodine lavage versus saline lavage in total joint arthroplasty. We previously reported no significant group differences at 3 months in a large multicenter randomized controlled trial. The present study reports 1-year outcomes of the same cohort. METHODS: In this prospective, multicenter trial, 2,053 high-risk patients undergoing primary, unilateral total hip arthroplasty (THA) or total knee arthroplasty (TKA) were randomized to one of four intraoperative protocols: vancomycin powder, dilute povidone-iodine, vancomycin povidone-iodine protocol (VPIP, combination), or saline lavage control. The primary outcome was 1-year PJI resulting in septic revision surgery. Analyses were conducted on a per-protocol basis using Chi-square tests stratified by procedure. At 1 year, complete follow-up was available for 798 THA and 1,032 TKA patients after accounting for withdrawals, loss to follow-up, and nine unrelated deaths. RESULTS: In the THA cohort, PJI occurred in 0.5% of vancomycin patients, 1.7% of iodine patients, 1.9% of VPIP patients, and 1.1% of saline patients (P = 0.62). In the TKA cohort, PJI occurred in 1.6% of vancomycin patients, none of the iodine patients, 2.0% of VPIP patients, and 0.4% of saline patients (P = 0.05). There were no significant differences between study groups at 0 to 3 months (P = 0.14 for THA, P = 0.13 for TKA), 3 to 12 months (P = 0.67 for THA, P = 0.80 for TKA), or combined 0 to 12 months (P = 0.62 for THA, P = 0.05 for TKA). CONCLUSIONS: There were no significant differences in 1-year PJI rates observed across prophylactic strategies in high-risk primary THA or TKA. These findings suggest that intraoperative antiseptic and antibiotic protocols may have limited influence on longer-term outcomes.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Saba BV, Long WJ, Higuera CA, et al. The One-Year Infection Rates After Vancomycin Powder and Dilute Povidone-Iodine Lavage in High-Risk Primary Total Joint Arthroplasty: A Multicenter Randomized Controlled Trial. J Arthroplasty. 2026. PMID: 42036089. doi:10.1016/j.arth.2026.04.064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。